{"id":527911,"date":"2021-01-28T10:30:01","date_gmt":"2021-01-28T10:30:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=527911"},"modified":"2021-01-28T10:30:01","modified_gmt":"2021-01-28T10:30:01","slug":"changing-market-dynamics-of-bardetbiedl-syndrome-market-in-the-7mm-by-delveinsight","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/changing-market-dynamics-of-bardetbiedl-syndrome-market-in-the-7mm-by-delveinsight_527911.html","title":{"rendered":"Changing Market Dynamics of Bardet-Biedl Syndrome Market in the 7MM by DelveInsight"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1611818964.png\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Changing Market Dynamics of Bardet-Biedl Syndrome Market in the 7MM by DelveInsight\" src=\"https:\/\/www.abnewswire.com\/uploads\/1611818964.png\" alt=\"Changing Market Dynamics of Bardet-Biedl Syndrome Market in the 7MM by DelveInsight\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>DelveInsight<\/strong> has launched a new report on <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/bardet-biedl-syndrome-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\"><strong>Bardet-Biedl Syndrome Market<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\">Bardet&ndash;Biedl syndrome (BBS) is an autosomal recessive inherited condition that affects many parts of the body. People with this syndrome have progressive visual impairment due to cone\u2010rod dystrophy; extra fingers or toes (polydactyly); truncal obesity; decreased function of the male gonads (hypogonadism); kidney abnormalities; and learning difficulties<\/p>\n<p style=\"text-align: justify;\">.<\/p>\n<p style=\"text-align: justify;\"><strong>Request for free sample copy-<\/strong> <a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/sample-request\/bardet-biedl-syndrome-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\"><strong>https:\/\/www.delveinsight.com\/sample-request\/bardet-biedl-syndrome-market <\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Bardet-Biedl Syndrome market report<\/strong> provides an edge while developing business strategies, by understanding trends shaping and driving the global <strong>Bardet-Biedl Syndrome market<\/strong><\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/bardet-biedl-syndrome-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\"><strong>Bardet-Biedl Syndrome Symptoms<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">This condition offers myriad symptoms which can vary up to a great extent, even among the individuals of the same family. Like, vision loss is one of the major symptoms of this syndrome which occurs in mid\u2010childhood. It occurs as the light\u2010sensing tissue at the back of the retina gradually deteriorates. Obesity is another characteristic feature of Bardet&ndash;Biedl syndrome. Abnormal weight gain typically begins in early childhood and continues to be an issue throughout life.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Key player of the Bardet-Biedl Syndrome Market Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>Rhythm Pharmaceutical<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Bardet-Biedl Syndrome Market Report &amp; It&rsquo;s Research<\/strong><\/p>\n<p style=\"text-align: justify;\">BBS can result from mutations in at least 14 different genes (often called BBS genes). These genes are known or suspected to play critical roles in cell structures called cilia, leading to structural and functional problems in cilia. Defects in these cell structures probably disrupt important chemical signaling pathways during development and lead to abnormalities of sensory perception. Researchers believe that defective cilia are responsible for most of the features of Bardet&ndash;Biedl syndrome.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/bardet-biedl-syndrome-market?utm_source=SatPR&amp;utm_medium=pressrelease&amp;utm_campaign=ypr\" target=\"_blank\"><strong>Bardet-Biedl Syndrome Treatment<\/strong><\/a><\/p>\n<p style=\"text-align: justify;\">Currently, there is no cure for Bardet&ndash;Biedl syndrome. Treatment generally focuses on the specific signs and symptoms in each individual. A multidisciplinary approach is required to manage this pleiotropic condition effectively. Some of the physical abnormalities associated with BBS can be corrected with surgery, including extra digits, and some genitourinary abnormalities and congenital heart defects. As with any genetic condition, genetic counseling is recommended for affected individuals and their families.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Bardet-Biedl Syndrome Market Insights<\/strong><\/p>\n<p style=\"text-align: justify;\">BBS is generally diagnosed based upon identification of characteristic findings described earlier (e.g., visual problems due to retinal dystrophy, truncal obesity, and postaxial polydactyly). As diagnosis is based on clinical findings and BBS is associated with variable expression of the classical features, some patients may not have a clear diagnosis for many years.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Bardet-Biedl Syndrome Report Scope<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report covers the descriptive overview of Bardet-Biedl Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies<\/li>\n<li>Comprehensive insight has been provided into the Bardet-Biedl Syndrome epidemiology and treatment in the 7MM<\/li>\n<li>Additionally, an all-inclusive account of both the current and emerging therapies for Bardet-Biedl Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape<\/li>\n<li>A detailed review of Bardet-Biedl Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM<\/li>\n<li>The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Bardet-Biedl Syndrome market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Table of content<\/strong><\/p>\n<p style=\"text-align: justify;\">1. Key Insights<\/p>\n<p style=\"text-align: justify;\">2. Executive Summary of Bardet-Biedl Syndrome<\/p>\n<p style=\"text-align: justify;\">3. Competitive Intelligence Analysis for Bardet-Biedl Syndrome<\/p>\n<p style=\"text-align: justify;\">4. Bardet-Biedl Syndrome: Market Overview at a Glance<\/p>\n<p style=\"text-align: justify;\">5. Bardet-Biedl Syndrome: Disease Background and Overview<\/p>\n<p style=\"text-align: justify;\">6. Patient Journey<\/p>\n<p style=\"text-align: justify;\">7. Bardet-Biedl Syndrome Epidemiology and Patient Population<\/p>\n<p style=\"text-align: justify;\">8. Treatment Algorithm, Current Treatment, and Medical Practices<\/p>\n<p style=\"text-align: justify;\">9. Unmet Needs<\/p>\n<p style=\"text-align: justify;\">10. Key Endpoints of Bardet-Biedl Syndrome Treatment<\/p>\n<p style=\"text-align: justify;\">11. Marketed Products<\/p>\n<p style=\"text-align: justify;\">12. Emerging Therapies<\/p>\n<p style=\"text-align: justify;\">13. Bardet-Biedl Syndrome: Seven Major Market Analysis<\/p>\n<p style=\"text-align: justify;\">14. Attribute analysis<\/p>\n<p style=\"text-align: justify;\">15. 7MM: Market Outlook<\/p>\n<p style=\"text-align: justify;\">16. Access and Reimbursement Overview of Bardet-Biedl Syndrome<\/p>\n<p style=\"text-align: justify;\">17. KOL Views<\/p>\n<p style=\"text-align: justify;\">18. Market Drivers<\/p>\n<p style=\"text-align: justify;\">19. Market Barriers<\/p>\n<p style=\"text-align: justify;\">20. Appendix<\/p>\n<p style=\"text-align: justify;\">21. <strong>DelveInsight<\/strong> Capabilities<\/p>\n<p style=\"text-align: justify;\">22. Disclaimer<\/p>\n<p style=\"text-align: justify;\">23. About <strong>DelveInsight<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>&nbsp;<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Reasons to buy<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li>The report will help in developing business strategies by understanding trends shaping and driving the Bardet-Biedl Syndrome market<\/li>\n<li>To understand the future market competition in the Bardet-Biedl Syndrome market and Insightful review of the key market drivers and barriers<\/li>\n<li>Organize sales and marketing efforts by identifying the best opportunities for Bardet-Biedl Syndrome in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan<\/li>\n<li>Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors<\/li>\n<li>Organize sales and marketing efforts by identifying the best opportunities for Bardet-Biedl Syndrome market<\/li>\n<li>To understand the future market competition in the Bardet-Biedl Syndrome market<\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Related Report<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><a rel=\"nofollow\" href=\"https:\/\/www.delveinsight.com\/report-store\/bardet-biedl-syndrome-pipeline-insight\" target=\"_blank\"><strong>Bardet-Biedl&nbsp;Syndrome&nbsp;Pipeline<\/strong><\/a><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/delveinsight.com_56402.html\" rel=\"nofollow\">DelveInsight Business Research LLP<\/a><br \/><strong>Contact Person:<\/strong> Yash Bhardwaj<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=changing-market-dynamics-of-bardetbiedl-syndrome-market-in-the-7mm-by-delveinsight\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> +919650213330<br \/><strong>Address:<\/strong>304 S. Jones Blvd #2432  <br \/><strong>City:<\/strong> Las Vegas<br \/><strong>State:<\/strong> NV<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.delveinsight.com\/<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.delveinsight.com\/\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=changing-market-dynamics-of-bardetbiedl-syndrome-market-in-the-7mm-by-delveinsight\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; DelveInsight has launched a new report on Bardet-Biedl Syndrome Market &nbsp; Bardet&ndash;Biedl syndrome (BBS) is an autosomal recessive inherited condition that affects many parts of the body. People with this syndrome have progressive visual impairment due to cone\u2010rod dystrophy; &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/changing-market-dynamics-of-bardetbiedl-syndrome-market-in-the-7mm-by-delveinsight_527911.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[406,423,413],"tags":[],"class_list":["post-527911","post","type-post","status-publish","format-standard","hentry","category-Pharmaceuticals-Biotech","category-Professional-Services","category-Services"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/527911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=527911"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/527911\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=527911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=527911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=527911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}